Manlio Fusciello

916 total citations
25 papers, 564 citations indexed

About

Manlio Fusciello is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Manlio Fusciello has authored 25 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 17 papers in Oncology and 11 papers in Genetics. Recurrent topics in Manlio Fusciello's work include Immunotherapy and Immune Responses (18 papers), CAR-T cell therapy research (15 papers) and Virus-based gene therapy research (11 papers). Manlio Fusciello is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), CAR-T cell therapy research (15 papers) and Virus-based gene therapy research (11 papers). Manlio Fusciello collaborates with scholars based in Finland, Italy and Netherlands. Manlio Fusciello's co-authors include Vincenzo Cerullo, Sara Feola, Erkko Ylösmäki, Beatriz Martins, Cristian Capasso, Jacopo Chiaro, Firas Hamdan, Karita Peltonen, Jouni Hirvonen and Hélder A. Santos and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Manlio Fusciello

25 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manlio Fusciello Finland 15 264 263 236 183 115 25 564
Beatriz Martins Finland 14 317 1.2× 266 1.0× 218 0.9× 161 0.9× 114 1.0× 20 598
Sara Feola Finland 17 333 1.3× 344 1.3× 292 1.2× 235 1.3× 117 1.0× 33 685
Nicolas Boisgerault France 14 275 1.0× 206 0.8× 201 0.9× 343 1.9× 65 0.6× 25 688
Firas Hamdan Finland 11 216 0.8× 160 0.6× 171 0.7× 93 0.5× 92 0.8× 20 453
Cristian Capasso Finland 16 323 1.2× 388 1.5× 210 0.9× 324 1.8× 114 1.0× 23 709
Michal M. Raczy United States 9 226 0.9× 279 1.1× 408 1.7× 51 0.3× 165 1.4× 15 711
Meijun Zheng China 12 501 1.9× 231 0.9× 251 1.1× 314 1.7× 98 0.9× 26 806
Coralie M. Backlund United States 13 199 0.8× 329 1.3× 309 1.3× 71 0.4× 132 1.1× 18 663
João Paulo Portela Catani Belgium 9 251 1.0× 211 0.8× 370 1.6× 57 0.3× 66 0.6× 18 621

Countries citing papers authored by Manlio Fusciello

Since Specialization
Citations

This map shows the geographic impact of Manlio Fusciello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manlio Fusciello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manlio Fusciello more than expected).

Fields of papers citing papers by Manlio Fusciello

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manlio Fusciello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manlio Fusciello. The network helps show where Manlio Fusciello may publish in the future.

Co-authorship network of co-authors of Manlio Fusciello

This figure shows the co-authorship network connecting the top 25 collaborators of Manlio Fusciello. A scholar is included among the top collaborators of Manlio Fusciello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manlio Fusciello. Manlio Fusciello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feola, Sara, Firas Hamdan, Salvatore Russo, et al.. (2024). Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors. Journal for ImmunoTherapy of Cancer. 12(3). e008342–e008342. 7 indexed citations
2.
Fusciello, Manlio, Firas Hamdan, Salvatore Russo, et al.. (2024). Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches. Bioactive Materials. 45. 115–127. 8 indexed citations
3.
Hamdan, Firas, Salvatore Russo, Manlio Fusciello, et al.. (2023). Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses. Molecular Therapy — Oncolytics. 28. 264–276. 2 indexed citations
4.
Hamdan, Firas, Manlio Fusciello, & Vincenzo Cerullo. (2023). Personalizing Oncolytic Virotherapy. Human Gene Therapy. 34(17-18). 870–877. 4 indexed citations
5.
Fusciello, Manlio, Erkko Ylösmäki, Sara Feola, et al.. (2022). A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella. Molecular Therapy — Oncolytics. 25. 137–145. 3 indexed citations
6.
Feola, Sara, Salvatore Russo, Beatriz Martins, et al.. (2022). Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine. Frontiers in Immunology. 13. 826164–826164. 14 indexed citations
7.
Feola, Sara, Jacopo Chiaro, Beatriz Martins, et al.. (2022). A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines. eLife. 11. 26 indexed citations
8.
Ylösmäki, Erkko, Manlio Fusciello, Beatriz Martins, et al.. (2021). Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin. Journal for ImmunoTherapy of Cancer. 9(7). e002707–e002707. 22 indexed citations
9.
Guenther, Carla, Manlio Fusciello, Heidi Harjunpää, et al.. (2021). β2-Integrin Adhesion Regulates Dendritic Cell Epigenetic and Transcriptional Landscapes to Restrict Dendritic Cell Maturation and Tumor Rejection. Cancer Immunology Research. 9(11). 1354–1369. 15 indexed citations
10.
Chiaro, Jacopo, Thomas Whalley, Cristian Capasso, et al.. (2021). Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma. Cancer Immunology Research. 9(8). 981–993. 25 indexed citations
11.
Ylösmäki, Erkko, Manlio Fusciello, Beatriz Martins, et al.. (2021). Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform. Molecular Therapy — Oncolytics. 20. 459–469. 37 indexed citations
12.
Hamdan, Firas, Beatriz Martins, Sara Feola, et al.. (2021). GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses. Molecular Therapy — Methods & Clinical Development. 20. 625–634. 8 indexed citations
13.
Tähtinen, Siri, Sara Feola, Cristian Capasso, et al.. (2020). Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy. Cancer Research. 80(12). 2575–2585. 40 indexed citations
14.
Fontana, Flavia, Manlio Fusciello, Christianne Groeneveldt, et al.. (2019). Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor. ACS Nano. 13(6). 6477–6490. 40 indexed citations
15.
Fusciello, Manlio, Flavia Fontana, Siri Tähtinen, et al.. (2019). Artificially cloaked viral nanovaccine for cancer immunotherapy. Nature Communications. 10(1). 5747–5747. 97 indexed citations
16.
Polini, Beatrice, Sara Carpi, Beatriz Martins, et al.. (2019). Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy. PLoS ONE. 14(10). e0224072–e0224072. 7 indexed citations
17.
Lopes, Alessandra, Sara Feola, Manlio Fusciello, et al.. (2019). Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site. Journal for ImmunoTherapy of Cancer. 7(1). 174–174. 17 indexed citations
18.
Feola, Sara, Cristian Capasso, Manlio Fusciello, et al.. (2018). Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors. OncoImmunology. 7(8). e1457596–e1457596. 40 indexed citations
19.
Ylösmäki, Erkko, Cristian Capasso, Manlio Fusciello, et al.. (2018). Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses. Molecular Therapy. 26(9). 2315–2325. 39 indexed citations
20.
Pintilie, Melania, Hala Muaddi, Selim Chaib, et al.. (2016). MATE2 Expression Is Associated with Cancer Cell Response to Metformin. PLoS ONE. 11(12). e0165214–e0165214. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beatriz Martins Breakdown of academic impact, for papers by Sara Feola Breakdown of academic impact, for papers by Nicolas Boisgerault Breakdown of academic impact, for papers by Firas Hamdan Breakdown of academic impact, for papers by Cristian Capasso Breakdown of academic impact, for papers by Michal M. Raczy Breakdown of academic impact, for papers by Meijun Zheng Breakdown of academic impact, for papers by Coralie M. Backlund Breakdown of academic impact, for papers by João Paulo Portela Catani
Rankless by CCL
2026